Profibrotic Role for Interleukin-4 in Cardiac Remodeling and Dysfunction

Area of Science:

• Cardiovascular Biology
• Immunology
• Fibrosis Research

Background:

• Elevated interleukin-4 (IL-4) is linked to cardiac fibrosis in hypertension and heart failure.
• Chronic IL-4 elevation may predispose the heart to angiotensin II-induced damage.

Purpose of the Study:

• To investigate the causal role of chronically elevated IL-4 in cardiac fibrosis and angiotensin II-induced cardiac damage.
• To explore the therapeutic potential of targeting IL-4 in cardiovascular disease.

Main Methods:

• Comparison of wild-type (high IL-4) and IL-4-deficient mice.
• Assessment of cardiac structure, function, fibrosis markers, and inflammatory cell infiltration.
• In vitro studies on mouse cardiac fibroblasts stimulated with IL-4.
• Angiotensin II administration to evaluate cardiac response in both mouse groups.

Main Results:

• IL-4-deficient mice showed significantly reduced cardiac fibrosis and preserved cardiac function compared to wild-type mice.
• IL-4-deficient mice were protected from angiotensin II-induced dilated cardiomyopathy.
• In vitro, IL-4 upregulated procollagen genes and stimulated collagen production in cardiac fibroblasts via STAT6 signaling.

Conclusions:

• Establishes a causal link between interleukin-4 and cardiac fibrosis and dysfunction.
• Highlights the critical role of IL-4 in angiotensin II-induced cardiac damage.
• Identifies IL-4 as a potential therapeutic target for treating cardiac fibrosis.